The primary project will focus upon translation of imaging agents and devices developed at The Baylor College of Medicine (BCM) and translated in Phase I studies at The Michael E. DeBakey Veterans Administration Medical Center (MEDVAMC) as well as at Ben Taub General Hospital (BTGH). Dual labeled imaging agents for nuclear and fluorescence imaging will be produced under the BCM and LI-COR expertise in the Chemistry Core;imaged with near-infrared (NIR) fluorescence imaging and tomography devices built and algorithms written in the Instrumentation and Tomography Task Specific Projects;and approved following combinational FDA applications developed with safety and toxicity data generated in the Preclinical Testing Core. Initially we will translate two established agents which target (i) cancer cells within the lymphatic space and (ii) the reorganization of the stromal lymph node compartment as a hallmark of tumor malignancy in both breast cancer and melanoma patients. The results from Task Specific Projects that successfully validate additional candidate imaging agents will then be fed into the infrastructure of the primary project to conduct Phase 1 and Phase I/I I studies demonstrating nodal staging in Nuclear Medicine, intraoperative guidance for lymph node removal, and accurate molecular pathology. Provisions for including other consortia members are "build into" the infrastructure of the network for nodal staging of cancer. This Network for Translational Research builds upon over a decade of development of (i) NIR conjugates for cancer targeting, (ii)novel instrumentation for time-dependent measurement of fluorescence in deep tissues, and (iii) innovative algorithms which enable non-contact imaging and integration with nuclear imaging modalities.
This Network for Translation Research will focus upon demonstrating dual-labeled imaging agents for nuclear and near-infrared molecular imaging for diagnostic nodal staging of cancer. If successful, diagnostic imaging could complement, guide, or even eliminate surgical resection of lymph nodes for staging purposes.
|Rasmussen, John C; Herbst, Karen L; Aldrich, Melissa B et al. (2014) An abnormal lymphatic phenotype is associated with subcutaneous adipose tissue deposits in Dercum's disease. Obesity (Silver Spring) 22:2186-92|
|Agollah, Germaine D; Gonzalez-Garay, Manuel L; Rasmussen, John C et al. (2014) Evidence for SH2 domain-containing 5'-inositol phosphatase-2 (SHIP2) contributing to a lymphatic dysfunction. PLoS One 9:e112548|
|Tan, I-Chih; Balaguru, Duraisamy; Rasmussen, John C et al. (2014) Investigational lymphatic imaging at the bedside in a pediatric postoperative chylothorax patient. Pediatr Cardiol 35:1295-300|
|Zhu, Banghe; Rasmussen, John C; Sevick-Muraca, Eva M (2014) A matter of collection and detection for intraoperative and noninvasive near-infrared fluorescence molecular imaging: to see or not to see? Med Phys 41:022105|
|Cisneros, Brandon T; Law, Justin J; Matson, Michael L et al. (2014) Stable confinement of positron emission tomography and magnetic resonance agents within carbon nanotubes for bimodal imaging. Nanomedicine (Lond) 9:2499-509|
|Zhu, Banghe; Wu, Grace; Robinson, Holly et al. (2013) Tumor margin detection using quantitative NIRF molecular imaging targeting EpCAM validated by far red gene reporter iRFP. Mol Imaging Biol 15:560-8|
|Ghosh, Sukhen C; Ghosh, Pradip; Wilganowski, Nathaniel et al. (2013) Multimodal chelation platform for near-infrared fluorescence/nuclear imaging. J Med Chem 56:406-16|
|Zhu, B; Tan, I-C; Rasmussen, J C et al. (2012) Validating the sensitivity and performance of near-infrared fluorescence imaging and tomography devices using a novel solid phantom and measurement approach. Technol Cancer Res Treat 11:95-104|
|Rasmussen, John C; Kwon, Sunkuk; Sevick-Muraca, Eva M et al. (2012) The role of lymphatics in cancer as assessed by near-infrared fluorescence imaging. Ann Biomed Eng 40:408-21|
|Kwon, S; Davies-Venn, C; Sevick-Muraca, E M (2012) In vivo dynamic imaging of intestinal motions using diet-related autofluorescence. Neurogastroenterol Motil 24:494-7|
Showing the most recent 10 out of 19 publications